Novel, non-colonizing, single-strain live biotherapeutic product ADS024 protects against Clostridioides difficile infection challenge in vivo .

World journal of gastrointestinal pathophysiology(2023)

引用 0|浏览1
暂无评分
摘要
Our findings, demonstrating efficacy of ADS024 in protecting against CDI challenge in mouse models, support the use of ADS024 in preventing recurrent CDI following standard antibiotic treatment.
更多
查看译文
关键词
live biotherapeutic product ads024,infection challenge,difficile</i> infection,non-colonizing,single-strain
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要